James M Martinez

James M Martinez

UNVERIFIED PROFILE

Are you James M Martinez?   Register this Author

Register author
James M Martinez

James M Martinez

Publications by authors named "James M Martinez"

Are you James M Martinez?   Register this Author

21Publications

209Reads

33Profile Views

Trial of Galcanezumab in Prevention of Episodic Cluster Headache.

N Engl J Med 2019 07;381(2):132-141

From the NIHR-Wellcome Trust King's Clinical Research Facility and SLaM Biomedical Research Centre, King's College London, and King's College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1813440DOI Listing
July 2019

Societal burden of cluster headache in the United States: a descriptive economic analysis.

J Med Econ 2018 Jan 29;21(1):107-111. Epub 2017 Nov 29.

a Eli Lilly and Company , Indianapolis , IN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2017.1404470DOI Listing
January 2018

The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study.

Ann Clin Psychiatry 2007 Jul-Sep;19(3):187-95

Department of Psychiatry, Massachusetts General Hospital, Boston, MA, and Menninger Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.crossref.org/iPage?doi=10.1080%2F1040123070146517
Publisher Site
http://dx.doi.org/10.1080/10401230701465178DOI Listing
January 2008

Vagus nerve stimulation therapy in a patient with treatment-resistant depression: a case report of long-term follow-up and battery end-of-service.

CNS Spectr 2006 Feb;11(2):143-7

Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
February 2006

An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.

J Clin Psychopharmacol 2005 Dec;25(6):552-60

Lilly Research Laboratories, Eli Lilly & Co, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
December 2005

Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD.

Psychiatr Serv 2005 Dec;56(12):1541-8

Mood Disorders Center, Menninger Department of Psychiatry, Baylor College of Medicine, Ben Taub Hospital, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://psychiatryonline.org/doi/abs/10.1176/appi.ps.56.12.15
Publisher Site
http://dx.doi.org/10.1176/appi.ps.56.12.1541DOI Listing
December 2005

Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.

J Clin Psychiatry 2005 Sep;66(9):1097-104

Brain Stimulation Laboratory, Department of Psychiatry, Medical University of South Carolina, Charleston, SC 29403, USA.

View Article

Download full-text PDF

Source
September 2005

Vagus nerve stimulation: current use and potential applications in child and adolescent psychiatry.

Child Adolesc Psychiatr Clin N Am 2005 Jan;14(1):177-91, viii

Menninger Department of Psychiatry, Baylor College of Medicine, 6655 Travis Road, Suite 560, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S105649930400066
Publisher Site
http://dx.doi.org/10.1016/j.chc.2004.07.003DOI Listing
January 2005

Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study.

Depress Anxiety 2004 ;19(1):20-3

Department of Psychiatry, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/da.10148DOI Listing
August 2004

Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.

Bipolar Disord 2004 Apr;6(2):139-43

Mood Disorders Program, Department of Psychiatry, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
April 2004

A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.

Am J Psychiatry 2003 May;160(5):996-8

Mood Disorders Center, Department of Psychiatry, Baylor College of Medicine, Suite 560, 6655 Travis Road, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.160.5.996DOI Listing
May 2003

Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study.

J Clin Psychiatry 2002 May;63(5):391-5

Mood Disorders Center, Department of Psychiatry, Baylor College of Medicine, Houston, Tex 77030, USA.

View Article

Download full-text PDF

Source
May 2002